Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies.

McCaw, Zachary R; Tian, Lu; Wei, Jiawei; Claggett, Brian Lee; Bretz, Frank; Fitzmaurice, Garrett; Wei, Lee-Jen

McCaw, Zachary R; Tian, Lu; Wei, Jiawei; Claggett, Brian Lee; Bretz, Frank; Fitzmaurice, Garrett; Wei, Lee-Jen.

Afiliação

McCaw ZR; 1600 Amphitheatre Parkway, Mountain View, California.
Tian L; Department of Biomedical Data Science, Stanford University, Stanford, California.
Wei J; Novartis Institutes for Biomedical Research Co., Shanghai, China.
Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Bretz F; Novartis Pharma AG, Basel, Switzerland.
Fitzmaurice G; Section for Medical Statistics, Medical University of Vienna, Vienna, Austria.
Wei LJ; Laboratory for Psychiatric Biostatistics, McLean Hospital, Belmont, Massachusetts.

Stat Med ; 40(28): 6235-6242, 2021 12 10.

Article em En | MEDLINE | ID: mdl-34783094

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article